Back to ARCT overview

ARCT Arcturus Therapeutics Holdings PE ratio, current and historical analysis

As of Feb 23, 2024, the Arcturus Therapeutics Holdings stock's PE ratio is 9.95. This results from the current EPS of $3.76 and stock price of $37.42. The P/E ratio has a decrease of 43% from the past four quarters average of 17.6.

ARCT PE ratio history

How has ARCT's PE ratio performed in the past

Arcturus Therapeutics Holdings PE ratio by year

Year PE ratio Change
2022 48.46 N/A
2021 N/A N/A
2020 N/A N/A
2019 N/A N/A
2018 N/A N/A
2017 N/A N/A
2016 N/A N/A
2015 N/A N/A
2014 N/A N/A
2013 N/A N/A

ARCT average PE ratio chart

What is the average PE ratio of ARCT for the past years
3-year avg
5-year avg
10-year avg
15-year avg

ARCT PE vs peers

What is ARCT's PE ratio compared to its peers
Stock name PE ratio Market cap
ARCT Arcturus Therapeutics Holdings Inc 10.34 $1.04B
NWBO Northwest Biotherapeutics Inc N/A $636.35M

Frequently asked questions

What is Arcturus Therapeutics Holdings's PE ratio?

ARCT's price to earnings ratio is 9.95 as of Feb 23, 2024.

Why is Arcturus Therapeutics Holdings's PE ratio so low?

ARCT's PE ratio is low because the stock price is relatively cheap compared to the earnings generated by the company.

How is ARCT's PE ratio calculated (Arcturus Therapeutics Holdings PE ratio formula)?

You can calculate the PE ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Feb 23, 2024), Arcturus Therapeutics Holdings's stock price is $37.42. The earnings per share for the trailing twelve months (TTM) ending Sep 2023 is $3.76. Therefore, Arcturus Therapeutics Holdings's P/E ratio for today is 9.95. PE RATIO(9.95) = STOCK PRICE($37.42) / TTM EPS($3.76)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.